| Cardiotoxic Pathway (Subcellular process) |
Up/Down |
Gene |
Pathway F1 score AUC rank |
| Adrenergic receptor signaling |
Down |
ZDHHC7 |
8 |
| Hippo signaling |
Down |
YAP1 |
13 |
| Myofibril formation |
Down |
XIRP1 |
6 |
| Hippo signaling |
Down |
WWTR1 |
13 |
| Hippo signaling |
Down |
WWC1 |
13 |
| Cellular cholesterol uptake and efflux |
Down |
VLDLR |
23 |
| HIF-1 receptor signaling pathway |
Down |
VHL |
20 |
| Thyroid hormone receptor signaling |
Up |
TRIP6 |
10 |
| Lysosomal glycoprotein degradation |
Up |
TPP1 |
2 |
| Thin myofilament organization |
Down |
TPM4 |
21 |
| Thin myofilament organization |
Down |
TPM2 |
21 |
| Thin myofilament organization |
Down |
TPM1 |
21 |
| Thin myofilament organization |
Down |
TNNI3 |
21 |
| Myofibril formation |
Down |
TMOD4 |
6 |
| Myofibril formation |
Down |
TMOD1 |
6 |
| Thyroid hormone receptor signaling |
Up |
THRB |
10 |
| Thyroid hormone receptor signaling |
Up |
THRA |
10 |
| Hippo signaling |
Down |
TEAD4 |
13 |
| Hippo signaling |
Down |
TEAD2 |
13 |
| Hippo signaling |
Down |
TEAD1 |
13 |
| Leptin receptor signaling |
Up |
STAT3 |
5 |
| Serine and glycine metabolism |
Up |
SRR |
19 |
| Cholesterol-sensitive control of SREBP activation |
Up |
SREBF2 |
15 |
| Cholesterol-sensitive control of SREBP activation |
Up |
SREBF1 |
15 |
| Cholesterol synthesis |
Up |
SQLE |
22 |
| Polyol pathway |
Down |
SORD |
4 |
| Leptin receptor signaling |
Up |
SOCS3 |
5 |
| Myofibril formation |
Down |
SMYD1 |
6 |
| Serine and glycine metabolism |
Up |
SLC1A5 |
19 |
| Serine and glycine metabolism |
Up |
SLC1A4 |
19 |
| Serine and glycine metabolism |
Up |
SHMT2 |
19 |
| Cholesterol synthesis |
Up |
SEC14L2 |
22 |
| Serine and glycine metabolism |
Up |
SDS |
19 |
| Citric acid cycle |
Up |
SDHD |
1 |
| Citric acid cycle |
Up |
SDHC |
1 |
| Citric acid cycle |
Up |
SDHB |
1 |
| Citric acid cycle |
Up |
SDHA |
1 |
| Desaturation of fatty acids |
Up |
SCD5 |
11 |
| Desaturation of fatty acids |
Up |
SCD |
11 |
| Cellular cholesterol uptake and efflux |
Down |
SCARB2 |
23 |
| Cellular cholesterol uptake and efflux |
Down |
SCARB1 |
23 |
| Cellular cholesterol uptake and efflux |
Down |
SCARA3 |
23 |
| Cholesterol-sensitive control of SREBP activation |
Up |
SCAP |
15 |
| Cholesterol synthesis |
Up |
SC5D |
22 |
| Hippo signaling |
Down |
SAV1 |
13 |
| Cellular cholesterol uptake and efflux |
Down |
SAA1 |
23 |
| Adrenergic receptor signaling |
Down |
RGS4 |
8 |
| Adrenergic receptor signaling |
Down |
RGS16 |
8 |
| Adrenergic receptor signaling |
Down |
RGS14 |
8 |
| Restriction point |
Up |
RB1 |
3 |
| Hippo signaling |
Down |
RASSF1 |
13 |
| Adrenergic receptor signaling |
Down |
RASD1 |
8 |
| Adrenergic receptor signaling |
Down |
RAPGEF4 |
8 |
| Adrenergic receptor signaling |
Down |
RAPGEF3 |
8 |
| Hippo signaling |
Down |
PTPN14 |
13 |
| Serine and glycine metabolism |
Up |
PSPH |
19 |
| Serine and glycine metabolism |
Up |
PSAT1 |
19 |
| Gap junction organization |
Down |
PRKCG |
24 |
| Adrenergic receptor signaling |
Down |
PPP1R9B |
8 |
| Cellular cholesterol uptake and efflux |
Down |
PON1 |
23 |
| Cholesterol synthesis |
Up |
PMVK |
22 |
| Serine and glycine metabolism |
Up |
PICK1 |
19 |
| Serine and glycine metabolism |
Up |
PHGDH |
19 |
| Restriction point |
Up |
PFKFB3 |
3 |
| Myofibril formation |
Down |
PDLIM5 |
6 |
| Citric acid cycle |
Up |
PDHB |
1 |
| Citric acid cycle |
Up |
PDHA2 |
1 |
| Citric acid cycle |
Up |
PDHA1 |
1 |
| Adrenergic receptor signaling |
Down |
PDE4D |
8 |
| Hippo signaling |
Down |
PAX3 |
13 |
| Gap junction organization |
Down |
PANX3 |
24 |
| Gap junction organization |
Down |
PANX2 |
24 |
| Gap junction organization |
Down |
PANX1 |
24 |
| Citric acid cycle |
Up |
OGDH |
1 |
| Cholesterol synthesis |
Up |
NSDHL |
22 |
| Hippo signaling |
Down |
NF2 |
13 |
| Lysosomal glycoprotein degradation |
Up |
NEU3 |
2 |
| Lysosomal glycoprotein degradation |
Up |
NEU1 |
2 |
| Thin myofilament organization |
Down |
NEBL |
21 |
| Thyroid hormone receptor signaling |
Up |
NCOR2 |
10 |
| Myofibril formation |
Down |
MYOZ1 |
6 |
| Myofibril formation |
Down |
MYOT |
6 |
| Myofibril formation |
Down |
MYOG |
6 |
| Cellular cholesterol uptake and efflux |
Down |
MYLIP |
23 |
| Cholesterol synthesis |
Up |
MVK |
22 |
| Cholesterol synthesis |
Up |
MVD |
22 |
| Cellular cholesterol uptake and efflux |
Down |
MSR1 |
23 |
| Cholesterol synthesis |
Up |
MSMO1 |
22 |
| Hippo signaling |
Down |
MOB1B |
13 |
| Hippo signaling |
Down |
MOB1A |
13 |
| Lysosomal glycoprotein degradation |
Up |
MFSD8 |
2 |
| Cholesterol-sensitive control of SREBP activation |
Up |
MBTPS2 |
15 |
| HIF-1 receptor signaling pathway |
Down |
MAPK3 |
20 |
| Cholesterol synthesis |
Up |
LSS |
22 |
| Thin myofilament organization |
Down |
LMOD3 |
21 |
| Hippo signaling |
Down |
LIMD1 |
13 |
| Leptin receptor signaling |
Up |
LEPR |
5 |
| Leptin receptor signaling |
Up |
LEP |
5 |
| Hippo signaling |
Down |
LATS2 |
13 |
| Hippo signaling |
Down |
LATS1 |
13 |
| Myofibril formation |
Down |
KLHL41 |
6 |
| Leptin receptor signaling |
Up |
KHDRBS1 |
5 |
| Cholesterol-sensitive control of SREBP activation |
Up |
INSIG2 |
15 |
| Cholesterol-sensitive control of SREBP activation |
Up |
INSIG1 |
15 |
| Lysosomal glycoprotein degradation |
Up |
IFI30 |
2 |
| Citric acid cycle |
Up |
IDH2 |
1 |
| Cholesterol synthesis |
Up |
HMGCS1 |
22 |
| Cholesterol synthesis |
Up |
HMGCR |
22 |
| HIF-1 receptor signaling pathway |
Down |
HIF1AN |
20 |
| HIF-1 receptor signaling pathway |
Down |
HIF1A |
20 |
| Adrenergic receptor signaling |
Down |
GRK5 |
8 |
| Transamination pathways |
Up |
GPT |
25 |
| Adrenergic receptor signaling |
Down |
GPR3 |
8 |
| Transamination pathways |
Up |
GOT2 |
25 |
| Transamination pathways |
Up |
GOT1 |
25 |
| Adrenergic receptor signaling |
Down |
GNB3 |
8 |
| Serine and glycine metabolism |
Up |
GLDC |
19 |
| Gap junction organization |
Down |
GJD2 |
24 |
| Gap junction organization |
Down |
GJC3 |
24 |
| Gap junction organization |
Down |
GJC2 |
24 |
| Gap junction organization |
Down |
GJC1 |
24 |
| Gap junction organization |
Down |
GJB6 |
24 |
| Gap junction organization |
Down |
GJB5 |
24 |
| Gap junction organization |
Down |
GJB4 |
24 |
| Gap junction organization |
Down |
GJB3 |
24 |
| Gap junction organization |
Down |
GJB2 |
24 |
| Gap junction organization |
Down |
GJB1 |
24 |
| Gap junction organization |
Down |
GJA8 |
24 |
| Gap junction organization |
Down |
GJA5 |
24 |
| Gap junction organization |
Down |
GJA4 |
24 |
| Gap junction organization |
Down |
GJA3 |
24 |
| Gap junction organization |
Down |
GJA1 |
24 |
| Citric acid cycle |
Up |
FH |
1 |
| Cholesterol synthesis |
Up |
FDPS |
22 |
| Cholesterol synthesis |
Up |
FDFT1 |
22 |
| Hippo signaling |
Down |
FAT4 |
13 |
| Desaturation of fatty acids |
Up |
FADS3 |
11 |
| Desaturation of fatty acids |
Up |
FADS2 |
11 |
| Desaturation of fatty acids |
Up |
FADS1 |
11 |
| Adrenergic receptor signaling |
Down |
EZR |
8 |
| HIF-1 receptor signaling pathway |
Down |
EGLN3 |
20 |
| HIF-1 receptor signaling pathway |
Down |
EGLN1 |
20 |
| Cholesterol synthesis |
Up |
EBP |
22 |
| Restriction point |
Up |
E2F1 |
3 |
| Hippo signaling |
Down |
DYRK1A |
13 |
| Adrenergic receptor signaling |
Down |
DLG1 |
8 |
| Citric acid cycle |
Up |
DLD |
1 |
| Citric acid cycle |
Up |
DLAT |
1 |
| Cholesterol synthesis |
Up |
DHCR7 |
22 |
| Cholesterol synthesis |
Up |
DHCR24 |
22 |
| Myofibril formation |
Down |
DES |
6 |
| Serine and glycine metabolism |
Up |
DAO |
19 |
| Cholesterol synthesis |
Up |
CYP51A1 |
22 |
| Cholesterol synthesis |
Up |
CYP46A1 |
22 |
| Cholesterol synthesis |
Up |
CYP27A1 |
22 |
| Desaturation of fatty acids |
Up |
CYB5R4 |
11 |
| HIF-1 receptor signaling pathway |
Down |
CUL2 |
20 |
| Lysosomal glycoprotein degradation |
Up |
CTSA |
2 |
| Citric acid cycle |
Up |
CS |
1 |
| Hippo signaling |
Down |
CRB3 |
13 |
| Hippo signaling |
Down |
CRB2 |
13 |
| HIF-1 receptor signaling pathway |
Down |
COMMD1 |
20 |
| HIF-1 receptor signaling pathway |
Down |
CITED2 |
20 |
| Restriction point |
Up |
CDKN2A |
3 |
| Restriction point |
Up |
CDKN1B |
3 |
| Restriction point |
Up |
CDKN1A |
3 |
| Restriction point |
Up |
CDK6 |
3 |
| Restriction point |
Up |
CCND3 |
3 |
| Restriction point |
Up |
CCND2 |
3 |
| Restriction point |
Up |
CCND1 |
3 |
| Transamination pathways |
Up |
CCBL2 |
25 |
| Transamination pathways |
Up |
CCBL1 |
25 |
| Biglycan synthesis |
Down |
BGN |
18 |
| Transamination pathways |
Up |
BCAT2 |
25 |
| Transamination pathways |
Up |
BCAT1 |
25 |
| Hippo signaling |
Down |
AXL |
13 |
| Adrenergic receptor signaling |
Down |
ARRB2 |
8 |
| Adrenergic receptor signaling |
Down |
ARRB1 |
8 |
| Cellular cholesterol uptake and efflux |
Down |
ARL4C |
23 |
| Hippo signaling |
Down |
ANKHD1 |
13 |
| Serine and glycine metabolism |
Up |
AMT |
19 |
| Hippo signaling |
Down |
AMOTL2 |
13 |
| Hippo signaling |
Down |
AMOTL1 |
13 |
| Hippo signaling |
Down |
AMOT |
13 |
| Polyol pathway |
Down |
AKR1B10 |
4 |
| Polyol pathway |
Down |
AKR1B1 |
4 |
| Polyol pathway |
Down |
AKR1A1 |
4 |
| Adrenergic receptor signaling |
Down |
AKAP5 |
8 |
| Adrenergic receptor signaling |
Down |
AKAP12 |
8 |
| Hippo signaling |
Down |
AJUBA |
13 |
| Transamination pathways |
Up |
AGXT |
25 |
| Lysosomal glycoprotein degradation |
Up |
AGA |
2 |
| Adrenergic receptor signaling |
Down |
ADRBK2 |
8 |
| Adrenergic receptor signaling |
Down |
ADRBK1 |
8 |
| Adrenergic receptor signaling |
Down |
ADRB3 |
8 |
| Adrenergic receptor signaling |
Down |
ADRB2 |
8 |
| Adrenergic receptor signaling |
Down |
ADRB1 |
8 |
| Adrenergic receptor signaling |
Down |
ADRA2A |
8 |
| Adrenergic receptor signaling |
Down |
ADRA1D |
8 |
| Adrenergic receptor signaling |
Down |
ADRA1B |
8 |
| Adrenergic receptor signaling |
Down |
ADCY6 |
8 |
| Adrenergic receptor signaling |
Down |
ADCY2 |
8 |
| Thin myofilament organization |
Down |
ACTA1 |
21 |
| Desaturation of fatty acids |
Up |
ACOX1 |
11 |
| Citric acid cycle |
Up |
ACO2 |
1 |
| Cellular cholesterol uptake and efflux |
Down |
ABCG4 |
23 |
| Cellular cholesterol uptake and efflux |
Down |
ABCG1 |
23 |
| Cellular cholesterol uptake and efflux |
Down |
ABCA7 |
23 |
| Cellular cholesterol uptake and efflux |
Down |
ABCA5 |
23 |
| Cellular cholesterol uptake and efflux |
Down |
ABCA12 |
23 |
| Cellular cholesterol uptake and efflux |
Down |
ABCA1 |
23 |
| Transamination pathways |
Up |
AADAT |
25 |
| Cholesterol synthesis |
Up |
6-Mar |
22 |
| Chloride TM transport |
Down |
|
17 |
| GCSF receptor signaling |
Up |
|
16 |
| PDGF receptor signaling |
Down |
|
14 |
| Potassium TM transport |
Up |
|
7 |
| VEGF receptor signaling |
Up |
|
12 |
| Water TM transport |
Down |
|
9 |